130 related articles for article (PubMed ID: 18676221)
1. Rifampicin resistance phenotyping of Brucella melitensis by rpoB gene analysis in clinical isolates.
Sayan M; Yumuk Z; Dündar D; Bilenoglu O; Erdenlig S; Yaşar E; Willke A
J Chemother; 2008 Aug; 20(4):431-5. PubMed ID: 18676221
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey.
Sayan M; Kılıc S; Uyanık MH
J Infect Chemother; 2012 Feb; 18(1):41-6. PubMed ID: 21826587
[TBL] [Abstract][Full Text] [Related]
3. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis.
Valdezate S; Navarro A; Medina-Pascual MJ; Carrasco G; Saéz-Nieto JA
J Antimicrob Chemother; 2010 Jan; 65(1):51-3. PubMed ID: 19861338
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
6. Cell membrane components of Brucella melitensis play important roles in the resistance of low-level rifampicin.
Yang X; Wu T; Liu W; Tian G; Zhao H; Piao D; Jiang H; Wu Q
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008888. PubMed ID: 33373362
[TBL] [Abstract][Full Text] [Related]
7. Genetic bases of the rifampin resistance phenotype in Brucella spp.
Marianelli C; Ciuchini F; Tarantino M; Pasquali P; Adone R
J Clin Microbiol; 2004 Dec; 42(12):5439-43. PubMed ID: 15583262
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective.
Johansen TB; Scheffer L; Jensen VK; Bohlin J; Feruglio SL
Sci Rep; 2018 Jun; 8(1):8538. PubMed ID: 29867163
[TBL] [Abstract][Full Text] [Related]
9. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis.
Srivastava K; Das R; Jakhmola P; Gupta P; Chauhan DS; Sharma VD; Singh HB; Sachan AS; Katoch VM
Indian J Med Res; 2004 Aug; 120(2):100-5. PubMed ID: 15347859
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
12. [Direct, rapid detection for rifampin susceptibility to M. tuberculosis].
Yu Y; Kang X; Jin L
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):299-301. PubMed ID: 11775860
[TBL] [Abstract][Full Text] [Related]
13. [Studies on mutation of rifampicin-resistant genes in M. tuberculosis].
Wu X; Zhang J; Zhuang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):329-32. PubMed ID: 11326886
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
Marianelli C; Graziani C; Santangelo C; Xibilia MT; Imbriani A; Amato R; Neri D; Cuccia M; Rinnone S; Di Marco V; Ciuchini F
J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297
[TBL] [Abstract][Full Text] [Related]
15. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.
Sharma M; Sethi S; Mishra B; Sengupta C; Sharma SK
Indian J Med Res; 2003 Feb; 117():76-80. PubMed ID: 12931842
[TBL] [Abstract][Full Text] [Related]
17. Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.
Sougakoff W; Rodrigue M; Truffot-Pernot C; Renard M; Durin N; Szpytma M; Vachon R; Troesch A; Jarlier V
Clin Microbiol Infect; 2004 Apr; 10(4):289-94. PubMed ID: 15059116
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
20. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]